Navigation Links
CLARO Receives FDA-Clearance for Treatment of Acne
Date:10/29/2008

Handheld Device is First to Use IPL to Clear Acne Blemishes

COSTA MESA, Calif., Oct. 29 /PRNewswire/ -- CLRS Technology today announced the CLARO acne-clearing device received marketing clearance by the US Food & Drug Administration (FDA) for treatment of mild to moderate inflammatory acne. CLARO, the first hand-held device to use Intense Pulsed Light (IPL) for treatment of acne, will be available by prescription January 2009 from medical professionals, including dermatologists, family practitioners and pediatricians.

"CLARO represents a new option for women and men of all ages who suffer from inflammatory acne," said Richard Oberreiter, CEO and Founder, CLRS Technology. "Unlike other at-home devices on the market for acne treatment, CLARO uses clinically proven Intense Pulsed Light (IPL) technology, combining heat and light to clear acne fast."

CLARO is the company's first entry into the $225 million home device category, a dynamic part of the personal care market. According to Medical Insight Inc., the category is anticipated to grow to $1 billion in sales by 2012 as major corporations enter the field, including Palomar with Gillette, Syneron and Procter & Gamble and Light BioScience with L'Oreal.

"I am very impressed with the science and engineering behind CLARO and believe it will be an important tool for anyone who struggles to clear their chronic or stubborn acne," said Dr. Ronald Moy Former Co-Chief of the Department of Dermatology and Chief of Dermatologic Surgery, UCLA and the lead investigator for CLARO clinical studies. "As physicians, we prescribe a variety of topical and oral treatments to fight acne, but people still experience the frustrations of flare-ups that wreck havoc on their self-esteem and their social life. My patients will be thrilled to have the efficacy of professional IPL technology in treating acne safely at their own convenience, whenever they need to."

Using proprietary technology, CLARO delivers a series of light pulses in 6 seconds that safely penetrate the skin to eliminate the bacteria that cause acne and reduce inflammation. Clinical studies demonstrate a 94.8% decrease in p. acnes bacteria after just one treatment.

CLRS Technology also announced the appointment of industry veteran Philip Charlton as Senior Vice President for International Distribution. As the founder of Photo Therapeutics Limited (PTL) Charlton led a pre-IPO financing round for that company that raised $25 million from institutional investors. He was also responsible for establishing and developing the Omnilux light therapy technology to a pre-eminent position throughout Europe, SE Asia and Australia. Charlton's role at CLRS Technology will be to drive product penetration in key global markets. In fact, the company already has a signed letter of intent from Paragon Global Marketing for distribution in South Korea, and is in final talks with multiple strategic and distribution partners both abroad and in the United States

CLARO will be available in three colors, Onyx Black, Hot Pink and Cobalt Blue. The lightweight unit is battery-operated and portable. The suggested price will be $275. For more information, visit http://www.myclaro.com.

CLRS Technology will be a participant in the 3rd Annual California Medical Device Forum, a "who's who" of medical device innovation nationwide, October 29-30 in Orange Country, CA (http://www.camedicaldeviceforum.com).

About CLRS Technology

Established in 2007, CLRS Technology is a manufacturing company that specializes in development of innovative and clinically proven consumer hand-held medical devices that deliver at-home solutions for common skin and allergy problems that were previously only available at a medical or aesthetic professional's office.


'/>"/>
SOURCE CLRS Technology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: